Literature DB >> 16113432

Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease.

Peter K Jeffery1.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are pathologically distinct in terms of their predominant inflammatory cells and structural alterations (i.e., remodeling). However, there are many cases of functional and pathologic overlap, supporting the author's view that use of the terms asthma or COPD is oversimplistic and fails to identify the range of phenotypes that exist. In general, there is epithelial fragility and thickening of the reticular basement membrane, even in mild asthma; increased airway smooth muscle mass, hypertrophy of mucus-secreting glands, increased vascularity, greater numbers of fibroblasts, and increased deposition of collagen in severe asthma and COPD; and mucous metaplasia, squamous metaplasia, and parenchymal destruction in COPD. Because of increased neutrophilia, patterns of inflammation become similar when exacerbations of asthma and COPD result in hospitalization. Moreover, in mild COPD, exacerbations of bronchitis are associated with mucosal eosinophilia and upregulation of RANTES, two features normally associated with asthma. The overlap may also be seen in intermediate thickening of the reticular basement membrane and eosinophilia in patients with COPD who demonstrate reversibility to oral steroid. Importantly, a recent study of "eosinophilic bronchitis" demonstrates a thickened reticular basement membrane and challenges our current concept of the histopathologic distinctions between asthma and COPD.

Entities:  

Mesh:

Year:  2004        PMID: 16113432     DOI: 10.1513/pats.200402-009MS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  100 in total

1.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

Review 2.  Pathogenetic and prognostic roles of bloodborne fibrocytes in asthma.

Authors:  Sabrina Mattoli
Journal:  J Zhejiang Univ Sci B       Date:  2015-08       Impact factor: 3.066

3.  Tumor necrosis factor family member LIGHT acts with IL-1β and TGF-β to promote airway remodeling during rhinovirus infection.

Authors:  A K Mehta; T Doherty; D Broide; M Croft
Journal:  Allergy       Date:  2018-03-01       Impact factor: 13.146

Review 4.  Using mouse genomics to understand idiopathic interstitial fibrosis.

Authors:  David M Brass; John Tomfohr; Ivana V Yang; David A Schwartz
Journal:  Proc Am Thorac Soc       Date:  2007-01

5.  The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma.

Authors:  Graziella Turato; Simonetta Baraldo; Renzo Zuin; Marina Saetta
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

Review 6.  The role of the epithelium in airway remodeling in asthma.

Authors:  Donna E Davies
Journal:  Proc Am Thorac Soc       Date:  2009-12

7.  Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter.

Authors:  Oliver J Brand; Sangeeta Somanath; Catherine Moermans; Haruhiko Yanagisawa; Mitsuo Hashimoto; Stephanie Cambier; Jennifer Markovics; Andrew J Bondesson; Arthur Hill; David Jablons; Paul Wolters; Jianlong Lou; James D Marks; Jody L Baron; Stephen L Nishimura
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

8.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

9.  Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment.

Authors:  Chan-Sun Park; Tae-Bum Kim; Keun Ae Moon; Yun-Jeong Bae; Hee Ran Lee; Min Kyoung Jang; Hee-Bom Moon; You Sook Cho
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

10.  Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro.

Authors:  Kazuhito Asano; Yusuke Shikama; Naruo Shoji; Kojiro Hirano; Harumi Suzaki; Hiroaki Nakajima
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.